1. Lipid lowering in acute coronary syndromes: New evidence, new questions

   • Gregory G. Schwartz
   • Anders G. Olsson

   Invited Commentary Pages: 1 - 3

2. Literature alert

   Announcement Pages: 5 - 7

3. Clinical trials report

   • Donald M. Black
   • Evan A. Stein

   OriginalPaper Pages: 11 - 13

4. Lipoprotein changes with statins

   • Evan A. Stein
   • Donald M. Black

   OriginalPaper Pages: 14 - 18

5. Statins in homozygous familial hypercholesterolemia

   • A. D. Marais
   • D. J. Blom
   • J. C. Firth

   OriginalPaper Pages: 19 - 25

6. Goals of statin therapy: Three viewpoints

   • Gilbert R. Thompson
   • Christopher J. Packard
   • Neil J. Stone

   ReviewPaper Pages: 26 - 33

7. A general assessment of the safety of HMG CoA reductase inhibitors (statins)

   • Donald M. Black

   OriginalPaper Pages: 34 - 41

8. Statins and inflammatory markers

   • Christopher C. Case
   • Christie M. Ballantyne

   OriginalPaper Pages: 42 - 47

9. Postmenopausal hormone replacement therapy as antiatherosclerotic therapy

   • Howard N. Hodis
   • Wendy J. Mack
   • Roger Lobo

   OriginalPaper Pages: 52 - 58

10. Peroxisome proliferator-activated receptors

    • Ouliana Ziouzenkova
    • Stephane Perrey
    • Jorge Plutzky

    OriginalPaper Pages: 59 - 64

11. Inhibition of acyl coenzyme a-cholesterol acyltransferase: A possible treatment of atherosclerosis?

    • Therese M. Heinonen

    OriginalPaper Pages: 65 - 70

12. Gut-acting drugs for lowering cholesterol

    • Donald M. Black

    OriginalPaper Pages: 71 - 75

13. Clinical trials report

    • Daniel Eisenberg

    OriginalPaper Pages: 76 - 76

14. Web alert

    Announcement Pages: 77 - 77